- Home
- SFM vs RPRX Comparison
SFM vs RPRX Comparison
Compare SFM & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFM
- RPRX
- Stock Information
- Founded
- SFM 2002
- RPRX 1996
- Country
- SFM United States
- RPRX United States
- Employees
- SFM N/A
- RPRX N/A
- Industry
- SFM Food Chains
- RPRX Biotechnology: Pharmaceutical Preparations
- Sector
- SFM Consumer Staples
- RPRX Health Care
- Exchange
- SFM Nasdaq
- RPRX Nasdaq
- Market Cap
- SFM 14.4B
- RPRX 15.6B
- IPO Year
- SFM 2013
- RPRX 2020
- Fundamental
- Price
- SFM $135.98
- RPRX $36.36
- Analyst Decision
- SFM Buy
- RPRX Strong Buy
- Analyst Count
- SFM 15
- RPRX 3
- Target Price
- SFM $168.20
- RPRX $45.33
- AVG Volume (30 Days)
- SFM 1.6M
- RPRX 3.9M
- Earning Date
- SFM 10-29-2025
- RPRX 11-05-2025
- Dividend Yield
- SFM N/A
- RPRX 2.42%
- EPS Growth
- SFM 52.36
- RPRX 54.86
- EPS
- SFM 4.84
- RPRX 2.32
- Revenue
- SFM $8,399,001,000.00
- RPRX $2,305,243,000.00
- Revenue This Year
- SFM $16.57
- RPRX $33.77
- Revenue Next Year
- SFM $11.38
- RPRX $4.62
- P/E Ratio
- SFM $28.12
- RPRX $15.64
- Revenue Growth
- SFM 16.83
- RPRX 3.02
- 52 Week Low
- SFM $100.59
- RPRX $24.05
- 52 Week High
- SFM $182.00
- RPRX $38.00
- Technical
- Relative Strength Index (RSI)
- SFM 34.81
- RPRX 50.51
- Support Level
- SFM $132.72
- RPRX $35.97
- Resistance Level
- SFM $141.24
- RPRX $36.94
- Average True Range (ATR)
- SFM 3.11
- RPRX 0.83
- MACD
- SFM -0.08
- RPRX 0.02
- Stochastic Oscillator
- SFM 22.58
- RPRX 71.33
About SFM Sprouts Farmers Market Inc.
Sprouts Farmers Market Inc offers a specialty grocery experience featuring an open layout with fresh produce at the heart of the store. Sprouts inspire wellness naturally with a carefully curated assortment products paired with purpose-driven people. The company continues to bring products made with lifestyle-friendly ingredients such as organic, plant-based, and gluten-free. It approximately has 407 stores in nearly 23 states. The Company has one operating segment that is healthy grocery stores.
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.